Polarization of natural killer T cells towards an NKT2 subpopulation occurs after stimulation with α-galactosylceramide and rhG-CSF in aplastic anemia

Acta Haematologica

Volumn 119, Issue 3, 2008, Pages 178-186

  Wang, Yingxue ^a   Hu, Xiaojing ^a   Guo, Chengshan ^b   Zhang, Qi ^b   Peng, Jun ^a   Zhang, Jianhua ^c   Li, Lizhen ^a   Zhang, Ti ^a   Xu, Conggao ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Galactosylceramide; Aplastic anemia; Cytokines; Natural killer T cells; NKT2

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 4; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW CELL; CELL EXPANSION; CELL FRACTIONATION; CELL STIMULATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MALE; MONONUCLEAR CELL; NATURAL KILLER T CELL; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; T LYMPHOCYTE ACTIVATION;

ADULT; ANEMIA, APLASTIC; BONE MARROW; CELLS, CULTURED; DRUG EVALUATION, PRECLINICAL; FEMALE; GALACTOSYLCERAMIDES; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; TH2 CELLS;

EID: 46049112699     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000137501     Document Type: Article

References (37)

1. Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A, Locatelli F, Mori PG, Saracco P, Todeschini G, Coser P, lacopino P, van Lint MT, Gluckman E, for the European Group for Blood and Marrow Transplantation (EBMT) Working Party on SAA: Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood 1995;85:1348-1353.
2. Killick SB, Cox CV, Marsh JC, Gordon-Smith EC, Gibson FM: Mechanisms of bone marrow progenitor cell apoptosis in aplastic anaemia and the effect of anti-thymocyte globulin: examination of the role of the Fas-Fas-L interaction. Br J Haematol 2000;111:1164-1169.
3. Rosenfeld SJ, Kimball J, Vining D, Young NS: Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 1995;85:3058-3065.
4. Maciejewski JP, Hibbs JR, Anderson S, Katevas P, Young NS: Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure. Exp Hematol 1994;22:1102-1110.
5. Nisticò A, Young NS: γ-Interferon gene expression in the bone marrow of patients with aplastic anemia. Ann Intern Med 1994;120:463-469.
6. Hinterberger W, Adolf G, Aichinger G, Dudczak R, Geissler K, Hocker P, Huber C, Kalhs P, Knapp W, Koller U: Further evidence for lymphokine overproduction in severe aplastic anemia. Blood 1988;72:266-272.
7. Maciejewski JP, Kim S, Sloand E, Selleri C, Young NS: Sustained long-term hematologic recovery despite a marked quantitative defect in the stem cell compartment of patients with aplastic anemia after immunosuppressive therapy. Am J Hematol 2000;65:123-131.
8. Marsh JC, Chang J, Testa NG, Hows JM, Dexter TM: In vitro assessment of marrow 'stem cell' and stromal cell function in aplastic anaemia. Br J Haematol 1991;78:258-267.
9. Dellabona P, Padovan E, Casorati G, Brockhaus M, Lanzavecchia A: An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J Exp Med 1994;180:1171-1176.
10. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L: NKT cells: what's in a name? Nat Rev Immunol 2004;4:231-237.
11. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG: NKT cells: facts, functions and fallacies. Immunol Today 2000;21:573-583.
12. Kronenberg M, Gapin L: The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002;2:557-568.
13. Shimosaka A: Role of NKT cells and alpha-galactosylceramide. Int J Hematol 2002;76:277-279.
14. Romagnami S: T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 2000;85:9-18.
15. Tsuda H, Sakai M, Michimata T, Tanebe K, Hayakawa S, Saito S: Characterization of NKT cells in human peripheral blood and decidual lymphocytes. Am J Reprod Immunol 2001;45:295-302.
16. Nishimura T, Kitamura H, Iwakabe K, Yahata T, Ohta A, Sato M, Takeda K, Okumura K, Van Kaer L, Kawano T, Taniguchi M, Nakui M, Sekimoto M, Koda T: The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int Immunol 2000;12:987-994.
17. Smyth MJ, Godfrey DI: NKT cells and tumor immunity - a double-edged sword. Nat Immunol 2000;1:459-460.
18. Wilson SB, Delovitch TL: Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat Rev Immunol 2003;3:211-222.
19. Kadowaki N, Antonenko S, Ho S, Rissoan MC, Soumelis V, Porcelli SA, Lanier LL, Liu YJ: Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J Exp Med 2001;193:1221-1226.
20. Rozman C, Marin P, Nomdedeu B, Montserrat E: Criteria for severe aplastic anaemia. Lancet 1987;ii:955-957.
21. Camitta BM: What is the definition of cure for aplastic anemia? Acta Haematol 2000;103:16-18.
22. Tuzuner N, Bennett JM: Reference standards for bone marrow cellularity. Leuk Res 1994;18:645-647.
23. Yang Y, Bao M, Yoon JW: Intrinsic defects in the T-cell lineage results in natural killer T-cell deficiency and the development of diabetes in the nonobese diabetic mouse. Diabetes 2001;50:2691-2699.
24. Kent SC, Chen Y, Clemmings SM, Viglietta V, Kenyon NS, Ricordi C, Hering B, Hafler DA: Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells. J Immunol 2005;175:4458-4464.
25. Linsen L, Thewissen M, Baeten K, Somers V, Geusens P, Raus J, Stinissen P: Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritis. Arthritis Res Ther 2005;7:493-502.
26. Illes Z, Kondo T, Newcombe J, Oka N, Tabira T, Yamamura T: Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J Immunol 2000;164:4375-4381.
27. Apostolou I, Takahama Y, Belmant C, Kawano T, Huerre M, Marchal G, Cui J, Taniguchi M, Nakauchi H, Fournié JJ, Kourilsky P, Gachelin G: Murine natural killer T (NKT) cells contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci USA 1999;96:5141-5146.
28. Gansert JL, Kiessler V, Engele M, Wittke F, Röllinghoff M, Krensky AM, Porcelli SA, Modlin RL, Stenger S: Human NKT cells express granulysin and exhibit antimycobacterial activity. J Immunol 2003;170:3154-3161.
29. Metelitsa LS, Naidenko OV, Kant A, Wu HW, Loza MJ, Perussia B, Kronenberg M, Seeger RC: Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J Immunol 2001;167:3114-3122.
30. Molling JW, Kölgen W, van der Vliet HJ, Boomsma MF, Kruizenga H, Smorenburg CH, Molenkamp BG, Langendijk JA, Leemans CR, von Blomberg BM, Scheper RJ, van den Eertwegh AJ: Peripheral blood IFN-γ-secreting Vα24+Vβ11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load. Int J Cancer 2005;116:87-93.
31. Huang Y, Jiang EL, Zhou Z, He Y, Wang M, Liu QG, Zhai WJ, Han MZ: Ex vivo expansion of Vα24 natural killer T cells with α-galactosylceramide. Acta Acad Med Sin 2005;27:315-320.
32. Young NS, Maciejewski J: The pathophysiology of acquired aplastic anemia. N Engl J Med 1997;336:1365-1372.
33. Young NS: Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia. Semin Hematol 2000;37:3-14.
34. Giannakoulas NC, Karakantza M, Theodorou GL, Pagoni M, Galanopoulos A, Kakagianni T, Kouraklis-Symeonidis A, Matsouka P, Maniatis A, Zoumbos NC: Clinical relevance of balance between type 1 and type 2 immune responses of lymphocyte subpopulations in aplastic anaemia patients. Br J Haematol 2004;124:97-105.
35. Zeng W, Maciejewski JP, Chen G, Risitano AM, Kirby M, Kajigaya S, Young NS: Selective reduction of natural killer T cells in the bone marrow of aplastic anaemia. Br J Haematol 2002;119:803-809.
36. Crough T, Nieda M, Nicol AJ: Granulocyte colony-stimulating factor modulates α-galactosylceramide-responsive human Vα24+ Vβ11+ NKT cells. J Immunol 2004;173:4960-4966.
37. Ishikawa A, Motohashi S, Ishikawa E, Fuchida H, Higashino K, Otsuji M, Iizasa T, Nakayama T, Taniguchi M, Fujisawa T: A phase I study of α-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res 2005;11:1910-1917.